These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4106335

  • 21. Recognition of transplantation antigen in vitro: blocking of recognition structures by specific antibody.
    Ramseier H, Lindenmann J.
    Eur J Immunol; 1971 Nov; 1(5):348-51. PubMed ID: 4945638
    [No Abstract] [Full Text] [Related]

  • 22. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J, Fries D.
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract] [Full Text] [Related]

  • 23. Sex difference in specific and non-specific suppression of non-H-2 allograft responsiveness in mice.
    Nĕmec M.
    Folia Biol (Praha); 1971 Mar; 17(4):220-6. PubMed ID: 4943668
    [No Abstract] [Full Text] [Related]

  • 24. Passive serologic transfer of allograft immunity in immunologically suppressed mice. II. Effect of graft exposure to immune serum in primary hosts.
    Kinne DW, Simmons RL.
    J Immunol; 1971 Mar; 106(3):629-34. PubMed ID: 4926265
    [No Abstract] [Full Text] [Related]

  • 25. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ, Wood ML, Pompei R, Monaco AP.
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract] [Full Text] [Related]

  • 26. Dynamics of immunologic enhancement.
    Kaliss N.
    Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
    [No Abstract] [Full Text] [Related]

  • 27. Protective action of homologous serum component on graft rejection.
    Hasek M, Karakoz I, Skamene E, Chutna J, Nouza K, Bubenik J, Nemec M, Sovova V.
    Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266
    [No Abstract] [Full Text] [Related]

  • 28. Lymphocyte environment and the durability of transplantation tolerance.
    Levey RH.
    Transplant Proc; 1972 Sep; 4(3):395-9. PubMed ID: 4404152
    [No Abstract] [Full Text] [Related]

  • 29. The weaker the histoincompatibility, the greater the effectiveness of specific immunoblocking antibodies: a new immunogenetic rule of transplantation.
    Hildemann WH, Mullen Y.
    Transplant Proc; 1973 Mar; 5(1):617-20. PubMed ID: 4572121
    [No Abstract] [Full Text] [Related]

  • 30. An in vitro study on migration activity of spleen cells of allografted and antithymocytic serum treated animals.
    Kossowska-Paul B, Skopińska E, Wasik M, Wojtulewicz-Kurkus J.
    Bull Acad Pol Sci Biol; 1970 Mar; 18(12):749-51. PubMed ID: 4926240
    [No Abstract] [Full Text] [Related]

  • 31. Humoral factors in specific unresponsiveness to transplantation antigens.
    Brent L, Kilshaw PJ.
    Transplant Proc; 1976 Jun; 8(2):209-15. PubMed ID: 779181
    [No Abstract] [Full Text] [Related]

  • 32. Induction of cytotoxicity of lymphocytes from tolerant donors by antibodies to target cell alloantigens.
    Bubeník J, Perlmann P, Hasek M.
    Transplantation; 1970 Oct; 10(4):290-6. PubMed ID: 4251471
    [No Abstract] [Full Text] [Related]

  • 33. [Inhibition of the immune reaction following skin allograft by antithymocyte serum therapy of the donors].
    Petrányi G, Szegedi G, Fekete B.
    Orv Hetil; 1971 Aug 01; 112(31):1852-5. PubMed ID: 4941976
    [No Abstract] [Full Text] [Related]

  • 34. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U.
    Transfus Apher Sci; 2006 Aug 01; 35(1):45-58. PubMed ID: 16905361
    [Abstract] [Full Text] [Related]

  • 35. Induction of tolerance to antilymphocyte globulin in man.
    Weksler ME, Bull G, Schwartz GH, Stenzel KH, Rubin AL.
    Transplant Proc; 1971 Mar 01; 3(1):754-7. PubMed ID: 4937967
    [No Abstract] [Full Text] [Related]

  • 36. Graft rejection.
    Feldman JD.
    Arch Intern Med; 1969 Jun 01; 123(6):713-8. PubMed ID: 4890441
    [No Abstract] [Full Text] [Related]

  • 37. [Importance of the immunological enhancement for the survival time of a homologous graft].
    Benkö A.
    Z Gesamte Inn Med; 1971 Jun 01; 26(11):345-52. PubMed ID: 4397958
    [No Abstract] [Full Text] [Related]

  • 38. Cluster-forming cells and response to skin allografts.
    Micklem HS, Asfi C, Staines NA.
    Transplant Proc; 1971 Mar 01; 3(1):898-900. PubMed ID: 4937987
    [No Abstract] [Full Text] [Related]

  • 39. Immunological enhancement.
    Russell PS.
    Transplant Proc; 1971 Mar 01; 3(1):960-6. PubMed ID: 4941150
    [No Abstract] [Full Text] [Related]

  • 40. Antibodies to receptors recognizing histocompatibility antigens.
    Ramseier H.
    Curr Top Microbiol Immunol; 1973 Mar 01; 60():31-78. PubMed ID: 4577506
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.